ChemicalBook--->CAS DataBase List--->87725-72-2

87725-72-2

87725-72-2 Structure

87725-72-2 Structure
IdentificationBack Directory
[Name]

QNSWMJYOGMUVGO-REWXTUPXSA-N
[CAS]

87725-72-2
[Synonyms]

QNSWMJYOGMUVGO-REWXTUPXSA-N
[Molecular Formula]

C24H35ClN2O5
[MOL File]

87725-72-2.mol
[Molecular Weight]

466.998
Hazard InformationBack Directory
[Uses]

Trandolapril Hydrochloride is an antihypertensive. Angiotensin converting enzyme (ACE) inhibitor.
[in vivo]

Trandolapril hydrochloride (3 mg/kg/day; p.o.; 7 d) reduces renal fibrosis in obstructive nephropathy in mice, by inhibiting renal interstitial matrix expression and myofibroblast activation, decreasing renal proinflammatory cytokine RANTES and TNF-α level[2].
Trandolapril hydrochloride (0.3 mg/kg/day; p.o.; 4 weeks) improves arterial mechanics in rats, prevents arterial hypertrophy, collagen and cellular fibronectin accumulation[3].
randolapril (0.3 mg/kg/day; p.o.; 4 months) exhibits a chronic anti-hypertension effects in rats, results in blood pressure decreasing[3].
Trandolapril hydrochloride (0.25 mg/kg; p.o.; twice a day; 4 months) inhibits Atherosclerosis in the Watanabe Heritable Hyperlipidemic Rabbit[4].

Animal Model:UUD (unilateral ureteral obstruction) model in Male CD-1 mice (18-22 g)[2]
Dosage:3 mg/kg
Administration:Oral gavage; daily, for 7 days
Result:Resulted in renal interstitial matrix expression (including fibronectin, type I, and type III collagen) decreasing, and inhibited myofibroblast activation by surprising a-smooth muscle actin (a-SMA) expression, decreased the RANTES (regulated on activation, normal T cell expressed and secreted) and TNF-α level.
Animal Model:SHR model (spontaneously hypertensive rats, 4-week-old)[3]
Dosage:0.3 mg/kg
Administration:Oral gavage; daily for 4 weeks
Result:Reduced collagen content in the aortic media and increased ariterial distensibility up to about 80%.
Animal Model:Watanabe heritable hyperlipidemic rabbit (3 months old)[4]
Dosage:0.25 mg/kg
Administration:Oral gavage; twice a day; 9 months
Result:Decreased in atherosclerotic involvement of the intimal surface, and also decreased cholesterol content in descending thoracic aorta.
87725-72-2 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +8613564774135 , +8613564774135
Website:
Company Name: Shanghai Hanhong Scientific Co., Ltd.
Tel: +undefined17612118332 , +undefined17612118332
Website: ?www.hanhonggroup.com
Company Name: Energy Chemical  
Tel: 021-58432009 400-005-6266
Website: http://www.energy-chemical.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Company Name: Santa Cruz Biotechnology Inc  
Tel: 60936350
Website: http://www.scbt.com
Company Name: Pharma Affiliates  
Tel: 172-5066494
Website: https://www.chemicalbook.com/ShowSupplierProductsList694812/0.htm
Company Name: Pharmaffiliates Analytics and Synthetics P. Ltd  
Tel: +91-172-5066494
Website: www.pharmaffiliates.com
Company Name: CLEARSYNTH LABS LTD.  
Tel: +91-22-45045900
Website: www.clearsynth.com
Tags:87725-72-2 Related Product Information
1794829-04-1 1797984-80-5 1795142-64-1 159326-68-8 1356019-55-0

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.